A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) study

Bone

Volumn 50, Issue 4, 2012, Pages 917-924

  Zhao, Jing ^a   Xia, Weibo ^a   Nie, Min ^a   Zheng, Xin ^b   Wang, Qiuping ^c   Wang, Xiran ^d   Wang, Wenbo ^e   Ning, Zhiwei ^f   Huang, Wei ^g   Jiang, Yan ^a   Li, Mei ^a   Wang, Ou ^a   Xing, Xiaoping ^a   Sun, Yue ^a   Luo, Lianmei ^a   He, Shuli ^a   Yu, Wei ^a   Lin, Qiang ^a   Pei, Yu ^h   Zhang, Fan ^c   Han, Youxia ^g   Tong, Yanmin ^b   Che, Ying ^e   Shen, Ruixin ^f   Hu, Yingying ^a   Zhou, Xueying ^a   Chen, Qian ⁱ   Xu, Ling ^a   more..

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINA REHABILITATION RESEARCH CENTER   (China)

^c Beijing Liangxiang Hospital   (China)

^d General Hospital of the Second Artillery Force   (China)

^e PEKING UNIVERSITY SHOUGANG HOSPITAL   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g Beijing Haidian Hospital   (China)

^h CHINESE PLA GENERAL HOSPITAL   (China)

ⁱ BROWN UNIVERSITY   (United States)

Author keywords

25(OH)D; BMD; Bone turnover markers; MATN3; Vertebral fracture

Indexed keywords

25 HYDROXYVITAMIN D; AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; MATRILIN 3;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CHINESE; COMMUNITY LIVING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMUR NECK; FRACTURE; GENE; GENE FUNCTION; GENETIC ASSOCIATION; HAPLOTYPE; HEALTH HAZARD; HIP; HUMAN; LUMBAR SPINE; MATN3 GENE; MEDICAL HISTORY; POPULATION RESEARCH; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; CASE-CONTROL STUDIES; CHINA; COLLAGEN TYPE I; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PROCOLLAGEN; SPINAL FRACTURES; VITAMIN D;

EID: 84862790776     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.01.003     Document Type: Article

References (45)

1. Harris M., Nguyen T.V., Howard G.M., Kelly P.J., Eisman J.A. Genetic and environmental correlations between bone formation and bone mineral density: a twin study. Bone 1998, 22:141-145.
2. Slemenda C.W., Christian J.C., Williams C.J., Norton J.A., Johnston C.C. Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991, 6:561-567.
3. Duncan E.L., Cardon L.R., Sinsheimer J.S., Wass J.A., Brown M.A. Site and gender specificity of inheritance of bone mineral density. J Bone Miner Res 2003, 18:1531-1538.
4. Guéguen R., Jouanny P., Guillemin F., Kuntz C., Pourel J., Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 1995, 10:2017-2022.
5. Ardeňa G.J., Paz-Pacheco E., Jimeno C.A., Lantion-Ang F.L., Paterno E., Juban N. Knowledge, attitudes and practices of persons with type 2 diabetes in a rural community: phase I of the community-based Diabetes Self-Management Education (DSME) Program in San Juan, Batangas, Philippines. Diabetes Res Clin Pract 2010, 90:160-166.
6. Vaughan C.P., Brown C.J., Goode P.S., Burgio K.L., Allman R.M., Johnson T.M. The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract 2010, 64:577-583.
7. Wagener R., Kobbe B., Paulsson M. Primary structure of matrilin-3, a new member of a family of extracellular matrix proteins related to cartilage matrix protein (matrilin-1) and von Willebrand factor. FEBS Lett 1997, 413:129-134.
8. Budde B., Blumbach K., Ylöstalo J., Zaucke F., Ehlen H.W., Wagener R., et al. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol Cell Biol 2005, 25:10465-10478.
9. Wagener R., Ehlen H.W., Ko Y.P., Kobbe B., Mann H.H., Sengle G., et al. The matrilins-adaptor proteins in the extracellular matrix. FEBS Lett 2005, 579:3323-3329.
10. Claus S., Aubert-Foucher E., Demoor M., Camuzeaux B., Paumier A., Piperno M., et al. Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer cultures. J Cell Biochem 2010, 111:1642-1651.
11. Reneland R.H., Mah S., Kammerer S., Hoyal C.R., Marnellos G., Wilson S.G., et al. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med Genet 2005, 6:9.
12. Styrkarsdottir U., Cazier J.B., Kong A., Rolfsson O., Larsen H., Bjarnadottir E., et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 2003, 1:E69.
13. Babu L.R., Wilson S.G., Dick I.M., Islam F.M., Devine A., Prince R.L. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 2005, 36:555-561.
14. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
15. Freedman B.I., Bowden D.W., Ziegler J.T., Langefeld C.D., Lehtinen A.B., Rudock M.E., et al. Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res 2009, 24:1719-1727.
16. Lee H.J., Koh J.M., Hwang J.Y., Choi K.Y., Lee S.H., Park E.K., et al. Association of a RUNX2 promoter polymorphism with bone mineral density in postmenopausal Korean women. Calcif Tissue Int 2009, 84:439-445.
17. van der Weyden L., Wei L., Luo J., Yang X., Birk D.E., Adams D.J., et al. Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis. Am J Pathol 2006, 169:515-527.
18. Borochowitz Z.U., Scheffer D., Adir V., Dagoneau N., Munnich A., Cormier-Daire V. Spondylo-epi-metaphyseal dysplasia (SEMD) matrilin 3 type: homozygote matrilin 3 mutation in a novel form of SEMD. J Med Genet 2004, 41:366-372.
19. Cotterill S.L., Jackson G.C., Leighton M.P., Wagener R., Mäkitie O., Cole W.G., et al. Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3. Hum Mutat 2005, 26:557-565.
20. Fresquet M., Jackson G.C., Loughlin J., Briggs M.D. Novel mutations in exon 2 of MATN3 affect residues within the alpha-helices of the A-domain and can result in the intracellular retention of mutant matrilin-3. Hum Mutat 2008, 29:330.
21. Balemans W., Ebeling M., Patel N., Van Hul E., Olson P., Dioszegi M., et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001, 10:537-543.
22. Balemans W., Patel N., Ebeling M., Van Hul E., Wuyts W., Lacza C., et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 2002, 39:91-97.
23. Brunkow M.E., Gardner J.C., Ness J.V., Paeper B.W., Kovacevich B.R., Proll S., et al. Bone dysplasia sclerosteosis results from loss of the sost gene product, a novel cystine knot-containing protein. Am J Hum Genet 2001, 68:577-589.
24. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513-523.
25. Koller D.L., Ichikawa S., Johnson M.L., Lai D., Xuei X., Edenberg H.J., et al. Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 2005, 20:75-80.
26. Kornak U., Ostertag A., Branger S., Benichou O., de Vernejoul M.C. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II. J Clin Endocrinol Metab 2006, 91:995-1000.
27. Ralston S.H. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 2002, 87:2460-2466.
28. Huang Q.Y., Kung A.W. Genetics of osteoporosis. Mol Genet Metab 2006, 88:295-306.
29. Huang Q.Y., Li G.H., Cheung W.M., Song Y.Q., Kung A.W. Prediction of osteoporosis candidate genes by computational disease-gene identification strategy. J Hum Genet 2008, 53:644-655.
30. Zhang Z.H., Shen J.X., Liu Z.H. Retrospective study on standardization of BMD machines in China. Chin J Osteoporos 2005, 11:133-145.
31. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8:1137-1148.
32. Schuit S.C., van der Klift M., Weel A.E., de Laet C.E., Burger H., Seeman E., et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004, 34:195-202.
33. Watts N.B., Cooper C., Lindsay R., Eastell R., Manhart M.D., Barton I.P., et al. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom 2004, 7:255-261.
34. Lopes J.B., Danilevicius C.F., Takayama L., Caparbo V.F., Menezes P.R., Scazufca M., et al. Prevalence and risk factors of radiographic vertebral fracture in Brazilian community-dwelling elderly. Osteoporos Int 2011, 22:711-719.
35. Chapman K.L., Mortier G.R., Chapman K., Loughlin J., Grant M.E., Briggs M.D. Mutations in the region encoding the vonWillebrand factor Adomain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet 2001, 28:393-396.
36. Otten C., Hansen U., Talke A., Wagener R., Paulsson M., Zaucke F. A matrilin-3 mutation associated with osteoarthritis does not affect collagen affinity but promotes the formation of wider cartilage collagen fibrils. Hum Mutat 2010, 31:254-263.
37. Liu Y.Z., Pei Y.F., Liu J.F., Yang F. Powerful bivariate genome-wide association analyses suggest the SOX6 gene influencing both obesity and osteoporosis phenotypes in males. PLoS One 2009, 4:e6827.
38. Datta N.S., Abou-Samra A.B. PTH and PTHrP signaling in osteoblasts. Cell Signal 2009, 21:1245-1254.
39. Nicolae C., Ko Y.P., Miosge N., Niehoff A., Studer D., Enggist L., et al. Abnormal collagen fibrils in cartilage of matrilin-1/matrilin-3-deficient mice. J Biol Chem 2007, 282:22163-22175.
40. Stefánsson S.E., Jónsson H., Ingvarsson T., Manolescu I., Jónsson H.H., Olafsdóttir G., et al. Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3. Am J Hum Genet 2003, 72:1448-1459.
41. Min J.L., Meulenbelt I., Riyazi N., Kloppenburg M., Houwing-Duistermaat J.J., Seymour A.B., et al. Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand. Ann Rheum Dis 2006, 65:1060-1066.
42. Pullig O., Tagariello A., Schweizer A., Swoboda B., Schaller P., Winterpacht A. MATN3 (matrilin-3) sequence variation (pT303M) is a risk factor for osteoarthritis of the CMC1 joint of the hand, but not for knee osteoarthritis. Ann Rheum Dis 2007, 66:279-280.
43. Eliasson G.J., Verbruggen G., Stefansson S.E., Ingvarsson T., Jonsson H. Hand radiology characteristics of patients carrying the T(303)M mutation in the gene for matrilin-3. Scand J Rheumatol 2006, 35:138-142.
44. Rendina D., Gianfrancesco F., Filippo G.D., Merlotti D., Esposito T., Mingione A., et al. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol 2010, 163:165-172.
45. Roshandel D., Holliday K.L., Pye S.R., Boonen S., Borghs H., Vanderschueren D., et al. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res 2010, 25:1830-1838.